Certara, Inc.

Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat

Certara to Report First Quarter 2026 Financial Results on May 11th, 2026

Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib

Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance

Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025